The Pediatric Rheumatology International trials Organization Criteria for the Evaluation of Response to Therapy in Juvenile Systemic Lupus Erythematosus: Prospective validation of the disease activity core set. Arthritis Rheum 2005; 52: 2854-64

Ruperto, N; Ravelli, A; Cuttica, R; Espada, G; Ozen, S; Porras, O; Sztajnbok, F; Falcini, F; Kasapcopur, O; Venning, H; Bica, B; Merino, R; Ros J, Coto C.; Susic, G; Luz Gamir, M; Minden, K; See, Y; Uziel, Y; Mukamel, M; Riley, P; Zulian, F; Olivieri, An; Cimaz, Rolando; Girschick, H; Rumba, I; Cavuto, S; Pistorio, A; Lovell D, J.; For the Pediatric Rheumatology International Trials Organization, Martini A.; the Pediatric Rheumatology Collaborative Study Group,

doi:10.1002/art.21230

The Pediatric Rheumatology International Trials Organization Criteria for the Evaluation of Response to Therapy in Juvenile Systemic Lupus Erythematosus

The Pediatric Rheumatology International trials Organization Criteria for the Evaluation of Response to Therapy in Juvenile Systemic Lupus Erythematosus: Prospective validation of the disease activity core set. Arthritis Rheum 2005; 52: 2854-64 / Ruperto N; Ravelli A; Cuttica R; Espada G; Ozen S; Porras O; Sztajnbok F; Falcini F; Kasapcopur O; Venning H; Bica B; Merino R; Coto C. Ros J; Susic G; Luz Gamir M; Minden K; See Y; Uziel Y; Mukamel M; Riley P; Zulian F; Olivieri AN; Cimaz R; Girschick H; Rumba I; Cavuto S; Pistorio A; J. Lovell D; Martini A. For the Pediatric Rheumatology International Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).. - In: ARTHRITIS AND RHEUMATISM. - ISSN 1529-0131. - STAMPA. - 52:(2005), pp. 2854-2864. [10.1002/art.21230]